Your Strategic Partner in Life Sciences Collaboration
At Oxford Global, we connect solution providers with senior scientists and decision-makers working across drug discovery, development, manufacturing, and commercialisation. From cell and gene therapy to precision medicine, our events and platforms place your brand at the centre of the conversations shaping next-generation therapeutics.
Whether you're targeting niche modalities, therapeutic areas, or end-to-end pipelines, our flexible sponsorship options are designed to boost your visibility and support your sales cycle—so you reach the right partners, and ultimately, patients, faster.
Proteins, Antibodies & ADCs
Explore the latest in antibody discovery, next-gen therapeutic development, and bioprocess optimisation with leading scientists and innovators in the field, including;
- Antibody Discovery & Engineering
- Cell Line Development & Optimisation
- Downstream Processing Strategies
- Novel In Vitro Display Technologies
- ADC Design, Linker/ Payload Innovations
Peptides & Oligonucleotides
The programme will cover how data-driven design, sustainable synthesis, and advanced delivery tech are redefining peptide and oligonucleotide therapeutics—from discovery to clinical success. Featuring key topics;
- AI-Driven Peptide Design & Engineering
- Green Chemistry & Sustainable Manufacturing
- Analytical & Computational Tools for Oligo Therapeutics
- CRISPR/CAS Systems & Gene Editing
- Nanoparticle Delivery & Conjugation Strategies
- RNA Targeting & Clinical Development Pathways
Immunotherapy & Immuno-oncology
Uncover next-generation breakthroughs in immunotherapy, from novel cell-based treatments to multi-omics-driven target discovery. Explore key topics;
- Cell-Based & Cytokine Therapies
- Tolerization & Autoimmune Strategies
- Spatial Biology & Single-Cell Sequencing
- Translational & Humanized Model Systems
- Biomarker Discovery & Target Validation
- Tumour Microenvironment & IO Success
Vaccines
Discover the latest in vaccine R&D, covering mRNA and DNA platforms, antigen design, analytics, and clinical development. Key topics include:
- Novel nucleotide platforms
- Vaccine stability & immune profiling
- Preclinical and clinical advancements
- Automation and computational tools
- Insights from SARS-CoV-2 vaccine efforts
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
With tracks covering oligos, proteins, antibodies and peptides, you get different scientific perspectives and bump shoulders with people you normally wouldn’t. It’s friendly, well-organised, and creates opportunities for both science and business.
I've had really good interactions with people using and interested in my technology. That's why we come here - to discuss how we develop products of the future and understand the challenges the industry has.
NextGen Biomed fosters a diverse mix of companies from small, medium, and large pharma. Bringing everything happening in the field under one roof creates a great opportunity for interaction and collaboration.
